Medication Coverage

The US Food and Drug Administration (FDA) has approved two types of medications to treat cognitive symptoms of Alzheimer’s disease. When clinically indicated, these drugs can help manage symptoms associated with the progression of Alzheimer’s disease. The two types of medications are:

  • Cholinesterase inhibitors, which support communication among nerve cells. Examples include: Aricept®, Exelon® (patch or pill)
  • Memantine, which works by regulating the activity of glutamate, a messenger chemical involved in learning and memory. Example: Namenda®

Alternative Sources for Discounted Medications

Note: When purchasing prescription drugs online, patients should exercise caution. The FDA offers pointers on its website: fda.gov. Many pharmaceutical companies also offer discounts on their medications. Listed below are places to get additional information.

AARP Prescription Discount Program
(877) 422-7718
aarp.com

Costco
(800) 607-6861
Press 6 to locate a Costco pharmacy near you and talk to them about their specific discount medications.

Partnership for Prescription Assistance
(888) 477-2669
pparx.org

OptumRx
(800) 356-3477
optumrx.com

Rx Hope
Locate the names of prescription drugs which are available at low cost through the program in partnership with your doctor.
rxhope.com

NeedyMeds
(800) 503-6897
needymeds.org

Manufacturer Discounts

Sometimes, specific drug-makers offer discounts on certain drugs. For help specifically with paying for Alzheimer’s and dementia medications, see the following chart:

Medication Name Generic Drug Company Phone
Aricept® Donepezil Pfizer (800) 226-2072
Exelon® Rivastigmine Novartis (800) 245-5356
Namenda® Memantine AbbVic (844) 424-6727
Namzaric® n/a AbbVic (844) 424-6727

Source: brightfocus.org/alzheimers/article/financial-aid-alzheimers-medications

We make every effort to include as many relevant resources as possible; however, Alzheimer’s Los Angeles does not endorse the agencies listed in this directory nor was any payment received for their inclusion.